2-Methoxypyrimidine-5-boronic acid → 1-(1-Ethyl-3-methyl-1H-pyrazol-4-yl)-8-(2-methoxy-pyrimidin-5-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one

HRID 445561

反応式

HRID 445561 の反応式
Br[C:2]1[CH:11]=[CH:10][C:9]2[N:8]=[CH:7][C:6]3[N:12]([CH3:24])[C:13](=[O:23])[N:14]([C:15]4[C:16]([CH3:22])=[N:17][N:18]([CH2:20][CH3:21])[CH:19]=4)[C:5]=3[C:4]=2[CH:3]=1.[CH3:25][O:26][C:27]1[N:32]=[CH:31][C:30](B(O)O)=[CH:29][N:28]=1>>[CH2:20]([N:18]1[CH:19]=[C:15]([N:14]2[C:5]3[C:4]4[CH:3]=[C:2]([C:30]5[CH:29]=[N:28][C:27]([O:26][CH3:25])=[N:32][CH:31]=5)[CH:11]=[CH:10][C:9]=4[N:8]=[CH:7][C:6]=3[N:12]([CH3:24])[C:13]2=[O:23])[C:16]([CH3:22])=[N:17]1)[CH3:21]

参加物

3

反応物 2

HCID 27367782-Methoxypyrimidine-5-boronic acidHCID 596196758-bromo-1-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one2 回

生成物 1

HCID 596197451-(1-Ethyl-3-methyl-1H-pyrazol-4-yl)-8-(2-methoxy-pyrimidin-5-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one

実験手順

The title compound was synthesized in a similar manner as described for Example 1.1 using 8-bromo-1-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one (Intermediate F, 49 mg, 0.126 mmol) and 2-methoxy-5-pyrimidineboronic acid (ABCR, Karlsruhe, Germany, 25 mg, 0.162 mmol) to give the title compound as a white solid. (HPLC: tR 2.47 min (Method A); M+H=416 MS-ES; 1H-NMR (d6-DMSO, 400 MHz) 8.98 (s, 1H), 8.76-8.68 (m, 2H), 8.23-8.16 (m, 1H), 8.16-8.09 (m, 1H), 7.99-7.93 (m, 1H), 7.52-7.45 (m, 1H), 4.19 (q, 2H), 3.96 (s, 3H), 3.59 (s, 3H), 1.97 (s, 3H), 1.42 (t, 3H))

後処理

  1. customThe title compound was synthesized in a similar manner

出典と根拠

ORDレコード
ord-1309213f18d04eb4a8dcafd13538aad9
出典データセット
uspto-grants-2013_07
特許番号
US08476294B2

関連ノート

読み込み中…